{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T14:53:53Z","timestamp":1794408833085,"version":"4.9.0"},"reference-count":142,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T00:00:00Z","timestamp":1674604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T00:00:00Z","timestamp":1674604800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Cell Int"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Ovarian cancer (OC) is one of the most common gynecological malignancies with high morbidity and mortality. The peritoneum is one of the most common metastatic sites in ovarian cancer, involving large amounts of ascites. However, its mechanism is unclear. The peritoneal microenvironment composed of peritoneal effusion and peritoneum creates favorable conditions for ovarian cancer progression and metastasis. Here, we reviewed the peritoneal metastasis patterns and molecular mechanisms of ovarian cancer, as well as major components of the peritoneal microenvironment, peritoneal effusion, and immune microenvironment, and investigated the relationship between the peritoneal microenvironment and ovarian cancer metastasis.<\/jats:p>","DOI":"10.1186\/s12935-023-02854-5","type":"journal-article","created":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T07:02:49Z","timestamp":1674630169000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":109,"title":["Tumor microenvironment in ovarian cancer peritoneal metastasis"],"prefix":"10.1186","volume":"23","author":[{"given":"Shuangshuang","family":"Mei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,25]]},"reference":[{"issue":"1","key":"2854_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7\u201333.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"2854_CR2","doi-asserted-by":"publisher","first-page":"952","DOI":"10.3390\/ijms20040952","volume":"20","author":"MA Lisio","year":"2019","unstructured":"Lisio MA, Fu L, Goyeneche A, Gao ZH, Telleria C. High-grade serous ovarian cancer: basic sciences, clinical and therapeutic standpoints. Int J Mol Sci. 2019;20(4):952.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"2854_CR3","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.ygyno.2017.06.008","volume":"146","author":"JB Szender","year":"2017","unstructured":"Szender JB, Emmons T, Belliotti S, et al. Impact of ascites volume on clinical outcomes in ovarian cancer: a cohort study. Gynecol Oncol. 2017;146(3):491\u20137.","journal-title":"Gynecol Oncol"},{"issue":"11","key":"2854_CR4","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/S1470-2045(06)70939-1","volume":"7","author":"DS Tan","year":"2006","unstructured":"Tan DS, Agarwal R, Kaye SB. Mechanisms of transcoelomic metastasis in ovarian cancer. Lancet Oncol. 2006;7(11):925\u201334.","journal-title":"Lancet Oncol"},{"issue":"1","key":"2854_CR5","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov. 2022;12(1):31\u201346.","journal-title":"Cancer Discov"},{"issue":"2","key":"2854_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2020.188361","volume":"1873","author":"Y Jiang","year":"2020","unstructured":"Jiang Y, Wang C, Zhou S. Targeting tumor microenvironment in ovarian cancer: premise and promise. Biochim Biophys Acta Rev Cancer. 2020;1873(2): 188361.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"2854_CR7","volume-title":"Seminars in cancer biology","author":"E Schoutrop","year":"2022","unstructured":"Schoutrop E, Moyano-Galceran L, Lheureux S, et al. Molecular, cellular and systemic aspects of epithelial ovarian cancer and its tumor microenvironment. In: Seminars in cancer biology. London: Academic Press; 2022."},{"key":"2854_CR8","doi-asserted-by":"publisher","first-page":"14470","DOI":"10.1038\/ncomms14470","volume":"8","author":"A Yokoi","year":"2017","unstructured":"Yokoi A, Yoshioka Y, Yamamoto Y, et al. Malignant extracellular vesicles carrying MMP1 mRNA facilitate peritoneal dissemination in ovarian cancer. Nat Commun. 2017;8:14470.","journal-title":"Nat Commun"},{"issue":"10","key":"2854_CR9","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-002873","volume":"9","author":"J Fucikova","year":"2021","unstructured":"Fucikova J, Coosemans A, Orsulic S, et al. Immunological configuration of ovarian carcinoma: features and impact on disease outcome. J Immunother Cancer. 2021;9(10): e002873.","journal-title":"J Immunother Cancer"},{"issue":"4","key":"2854_CR10","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20191869","volume":"217","author":"A Etzerodt","year":"2020","unstructured":"Etzerodt A, Moulin M, Doktor TK, et al. Tissue-resident macrophages in omentum promote metastatic spread of ovarian cancer. J Exp Med. 2020;217(4): e20191869.","journal-title":"J Exp Med"},{"issue":"8","key":"2854_CR11","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.3390\/cancers11081044","volume":"11","author":"N Thomakos","year":"2019","unstructured":"Thomakos N, Diakosavvas M, Machairiotis N, Fasoulakis Z, Zarogoulidis P, Rodolakis A. Rare distant metastatic disease of ovarian and peritoneal carcinomatosis: a review of the literature. Cancers. 2019;11(8):1044.","journal-title":"Cancers"},{"key":"2854_CR12","first-page":"g8-10","volume":"2","author":"D Amadori","year":"1997","unstructured":"Amadori D, Sansoni E, Amadori A. Ovarian cancer: natural history and metastatic pattern. Front Biosci. 1997;2:g8-10.","journal-title":"Front Biosci"},{"issue":"12","key":"2854_CR13","doi-asserted-by":"publisher","first-page":"7606","DOI":"10.1245\/s10434-021-09899-8","volume":"28","author":"K Tanaka","year":"2021","unstructured":"Tanaka K, Shimada Y, Nishino K, et al. Clinical significance of mesenteric lymph node involvement in the pattern of liver metastasis in patients with ovarian cancer. Ann Surg Oncol. 2021;28(12):7606\u201313.","journal-title":"Ann Surg Oncol"},{"issue":"suppl_8","key":"2854_CR14","doi-asserted-by":"publisher","first-page":"viii61","DOI":"10.1093\/annonc\/mdx443","volume":"28","author":"EA Eisenhauer","year":"2017","unstructured":"Eisenhauer EA. Real-world evidence in the treatment of ovarian cancer. Ann Oncol. 2017;28(suppl_8):viii61\u20135.","journal-title":"Ann Oncol"},{"issue":"2","key":"2854_CR15","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s10585-020-10024-4","volume":"37","author":"AW Kastelein","year":"2020","unstructured":"Kastelein AW, Vos L, van Baal J, et al. Poor perfusion of the microvasculature in peritoneal metastases of ovarian cancer. Clin Exp Metastasis. 2020;37(2):293\u2013304.","journal-title":"Clin Exp Metastasis"},{"issue":"6","key":"2854_CR16","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nrc1098","volume":"3","author":"IJ Fidler","year":"2003","unstructured":"Fidler IJ. The pathogenesis of cancer metastasis: the \u2018seed and soil\u2019 hypothesis revisited. Nat Rev Cancer. 2003;3(6):453\u20138.","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"2854_CR17","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1136\/ijgc-00009577-200503000-00012","volume":"15","author":"A Fishman","year":"2005","unstructured":"Fishman A, Shalom-Paz E, Fejgin M, Gaber E, Altaras M, Amiel A. Comparing the genetic changes detected in the primary and secondary tumor sites of ovarian cancer using comparative genomic hybridization. Int J Gynecol Cancer. 2005;15(2):261\u20136.","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"2854_CR18","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.2353\/ajpath.2010.100105","volume":"177","author":"E Lengyel","year":"2010","unstructured":"Lengyel E. Ovarian cancer development and metastasis. Am J Pathol. 2010;177(3):1053\u201364.","journal-title":"Am J Pathol"},{"issue":"1","key":"2854_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijgo.2013.10.001","volume":"124","author":"J Prat","year":"2014","unstructured":"Prat J. Staging classification for cancer of the ovary, fallopian tube, and peritoneum. Int J Gynaecol Obstet. 2014;124(1):1\u20135.","journal-title":"Int J Gynaecol Obstet"},{"issue":"2","key":"2854_CR20","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s10585-021-10136-5","volume":"39","author":"D Dhaliwal","year":"2022","unstructured":"Dhaliwal D, Shepherd TG. Molecular and cellular mechanisms controlling integrin-mediated cell adhesion and tumor progression in ovarian cancer metastasis: a review. Clin Exp Metastasis. 2022;39(2):291\u2013301.","journal-title":"Clin Exp Metastasis"},{"issue":"1","key":"2854_CR21","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0898-6568(97)00074-0","volume":"10","author":"JA Buczek-Thomas","year":"1998","unstructured":"Buczek-Thomas JA, Chen N, Hasan T. Integrin-mediated adhesion and signalling in ovarian cancer cells. Cell Signal. 1998;10(1):55\u201363.","journal-title":"Cell Signal"},{"issue":"17","key":"2854_CR22","doi-asserted-by":"publisher","first-page":"7121","DOI":"10.1158\/0008-5472.CAN-08-4151","volume":"69","author":"NM Moss","year":"2009","unstructured":"Moss NM, Barbolina MV, Liu Y, Sun L, Munshi HG, Stack MS. Ovarian cancer cell detachment and multicellular aggregate formation are regulated by membrane type 1 matrix metalloproteinase: a potential role in Ip metastatic dissemination. Cancer Res. 2009;69(17):7121\u20139.","journal-title":"Cancer Res"},{"issue":"7","key":"2854_CR23","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1158\/0008-5472.CAN-07-5167","volume":"68","author":"K Sawada","year":"2008","unstructured":"Sawada K, Mitra AK, Radjabi AR, et al. Loss of E-cadherin promotes ovarian cancer metastasis via alpha 5-integrin, which is a therapeutic target. Cancer Res. 2008;68(7):2329\u201339.","journal-title":"Cancer Res"},{"issue":"2","key":"2854_CR24","first-page":"255","volume":"22","author":"N Auersperg","year":"2001","unstructured":"Auersperg N, Wong AS, Choi KC, Kang SK, Leung PC. Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr Rev. 2001;22(2):255\u201388.","journal-title":"Endocr Rev"},{"issue":"10","key":"2854_CR25","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1093\/annonc\/mdh387","volume":"15","author":"C Faleiro-Rodrigues","year":"2004","unstructured":"Faleiro-Rodrigues C, Macedo-Pinto I, Pereira D, Lopes CS. Prognostic value of E-cadherin immunoexpression in patients with primary ovarian carcinomas. Ann Oncol. 2004;15(10):1535\u201342.","journal-title":"Ann Oncol"},{"issue":"6","key":"2854_CR26","first-page":"2245","volume":"44","author":"Q Han","year":"2019","unstructured":"Han Q, Huang B, Huang Z, et al. Tumor cell-fibroblast heterotypic aggregates in malignant ascites of patients with ovarian cancer. Int J Mol Med. 2019;44(6):2245\u201355.","journal-title":"Int J Mol Med"},{"issue":"24","key":"2854_CR27","doi-asserted-by":"publisher","first-page":"11649","DOI":"10.1158\/0008-5472.CAN-05-2123","volume":"65","author":"L Rosan\u00f2","year":"2005","unstructured":"Rosan\u00f2 L, Spinella F, Di Castro V, et al. Endothelin-1 promotes epithelial-to-mesenchymal transition in human ovarian cancer cells. Cancer Res. 2005;65(24):11649\u201357.","journal-title":"Cancer Res"},{"issue":"1","key":"2854_CR28","doi-asserted-by":"publisher","first-page":"11913","DOI":"10.1038\/s41598-020-68639-2","volume":"10","author":"M Asem","year":"2020","unstructured":"Asem M, Young A, Oyama C, et al. Ascites-induced compression alters the peritoneal microenvironment and promotes metastatic success in ovarian cancer. Sci Rep. 2020;10(1):11913.","journal-title":"Sci Rep"},{"issue":"4","key":"2854_CR29","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/nrc3432","volume":"13","author":"E Kipps","year":"2013","unstructured":"Kipps E, Tan DS, Kaye SB. Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research. Nat Rev Cancer. 2013;13(4):273\u201382.","journal-title":"Nat Rev Cancer"},{"issue":"9","key":"2854_CR30","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1038\/bjc.1997.213","volume":"75","author":"L Bj\u00f8rge","year":"1997","unstructured":"Bj\u00f8rge L, Junnikkala S, Kristoffersen EK, Hakulinen J, Matre R, Meri S. Resistance of ovarian teratocarcinoma cell spheroids to complement-mediated lysis. Br J Cancer. 1997;75(9):1247\u201355.","journal-title":"Br J Cancer"},{"issue":"1","key":"2854_CR31","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.ygyno.2003.12.034","volume":"93","author":"KM Burleson","year":"2004","unstructured":"Burleson KM, Casey RC, Skubitz KM, Pambuccian SE, Oegema TR Jr, Skubitz AP. Ovarian carcinoma ascites spheroids adhere to extracellular matrix components and mesothelial cell monolayers. Gynecol Oncol. 2004;93(1):170\u201381.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"2854_CR32","doi-asserted-by":"publisher","first-page":"6298","DOI":"10.1038\/s41467-020-20140-0","volume":"11","author":"M Song","year":"2020","unstructured":"Song M, Yeku OO, Rafiq S, et al. Tumor derived UBR5 promotes ovarian cancer growth and metastasis through inducing immunosuppressive macrophages. Nat Commun. 2020;11(1):6298.","journal-title":"Nat Commun"},{"issue":"1","key":"2854_CR33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41416-020-0875-x","volume":"123","author":"CE Ford","year":"2020","unstructured":"Ford CE, Werner B, Hacker NF, Warton K. The untapped potential of ascites in ovarian cancer research and treatment. Br J Cancer. 2020;123(1):9\u201316.","journal-title":"Br J Cancer"},{"issue":"3","key":"2854_CR34","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1084\/jem.20180765","volume":"216","author":"Q Gao","year":"2019","unstructured":"Gao Q, Yang Z, Xu S, et al. Heterotypic CAF-tumor spheroids promote early peritoneal metastatis of ovarian cancer. J Exp Med. 2019;216(3):688\u2013703.","journal-title":"J Exp Med"},{"issue":"2","key":"2854_CR35","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.ygyno.2020.09.002","volume":"159","author":"G Gunay","year":"2020","unstructured":"Gunay G, Kirit HA, Kamatar A, Baghdasaryan O, Hamsici S, Acar H. The effects of size and shape of the ovarian cancer spheroids on the drug resistance and migration. Gynecol Oncol. 2020;159(2):563\u201372.","journal-title":"Gynecol Oncol"},{"issue":"25","key":"2854_CR36","doi-asserted-by":"publisher","first-page":"3315","DOI":"10.1038\/onc.2014.264","volume":"34","author":"Q Cai","year":"2015","unstructured":"Cai Q, Yan L, Xu Y. Anoikis resistance is a critical feature of highly aggressive ovarian cancer cells. Oncogene. 2015;34(25):3315\u201324.","journal-title":"Oncogene"},{"issue":"12","key":"2854_CR37","doi-asserted-by":"publisher","first-page":"4042","DOI":"10.1158\/1078-0432.CCR-10-3387","volume":"17","author":"M Zillhardt","year":"2011","unstructured":"Zillhardt M, Park SM, Romero IL, et al. Foretinib (GSK1363089), an orally available multikinase inhibitor of c-Met and VEGFR-2, blocks proliferation, induces anoikis, and impairs ovarian cancer metastasis. Clin Cancer Res. 2011;17(12):4042\u201351.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"2854_CR38","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1158\/0008-5472.CAN-21-0622","volume":"82","author":"U Ray","year":"2022","unstructured":"Ray U, Jung DB, Jin L, et al. Targeting LRRC15 inhibits metastatic dissemination of ovarian cancer. Cancer Res. 2022;82(6):1038\u201354.","journal-title":"Cancer Res"},{"issue":"11","key":"2854_CR39","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1038\/nm1125","volume":"10","author":"KW Cheng","year":"2004","unstructured":"Cheng KW, Lahad JP, Kuo WL, et al. The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers. Nat Med. 2004;10(11):1251\u20136.","journal-title":"Nat Med"},{"key":"2854_CR40","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.bbrc.2021.05.008","volume":"561","author":"Y Takeshita","year":"2021","unstructured":"Takeshita Y, Motohara T, Kadomatsu T, et al. Angiopoietin-like protein 2 decreases peritoneal metastasis of ovarian cancer cells by suppressing anoikis resistance. Biochem Biophys Res Commun. 2021;561:26\u201332.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"2854_CR41","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1002\/1878-0261.12845","volume":"15","author":"R Dolinschek","year":"2021","unstructured":"Dolinschek R, Hingerl J, Benge A, et al. Constitutive activation of integrin \u03b1v\u03b23 contributes to anoikis resistance of ovarian cancer cells. Mol Oncol. 2021;15(2):503\u201322.","journal-title":"Mol Oncol"},{"issue":"1","key":"2854_CR42","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/s41467-017-00411-z","volume":"8","author":"M Haemmerle","year":"2017","unstructured":"Haemmerle M, Taylor ML, Gutschner T, et al. Platelets reduce anoikis and promote metastasis by activating YAP1 signaling. Nat Commun. 2017;8(1):310.","journal-title":"Nat Commun"},{"issue":"22","key":"2854_CR43","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1001\/archinte.161.22.2733","volume":"161","author":"N Aslam","year":"2001","unstructured":"Aslam N, Marino CR. Malignant ascites: new concepts in pathophysiology, diagnosis, and management. Arch Intern Med. 2001;161(22):2733\u20137.","journal-title":"Arch Intern Med"},{"issue":"17","key":"2854_CR44","first-page":"5573","volume":"63","author":"VM Abrahams","year":"2003","unstructured":"Abrahams VM, Straszewski SL, Kamsteeg M, et al. Epithelial ovarian cancer cells secrete functional Fas ligand. Cancer Res. 2003;63(17):5573\u201381.","journal-title":"Cancer Res"},{"issue":"1","key":"2854_CR45","doi-asserted-by":"publisher","first-page":"273","DOI":"10.3390\/ijms19010273","volume":"19","author":"C Wefers","year":"2018","unstructured":"Wefers C, Duiveman-de Boer T, Zusterzeel P, et al. Different lipid regulation in ovarian cancer: inhibition of the immune system. Int J Mol Sci. 2018;19(1):273.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"2854_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0015625","volume":"5","author":"E Tran","year":"2010","unstructured":"Tran E, Nielsen JS, Wick DA, et al. Polyfunctional T-cell responses are disrupted by the ovarian cancer ascites environment and only partially restored by clinically relevant cytokines. PLoS ONE. 2010;5(12): e15625.","journal-title":"PLoS ONE"},{"issue":"1","key":"2854_CR47","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1186\/s12885-022-09534-z","volume":"22","author":"S Sato","year":"2022","unstructured":"Sato S, Matsushita H, Shintani D, et al. Association between effector-type regulatory T cells and immune checkpoint expression on CD8(+) T cells in malignant ascites from epithelial ovarian cancer. BMC Cancer. 2022;22(1):437.","journal-title":"BMC Cancer"},{"issue":"7727","key":"2854_CR48","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/s41586-018-0597-x","volume":"562","author":"M Song","year":"2018","unstructured":"Song M, Sandoval TA, Chae CS, et al. IRE1\u03b1-XBP1 controls T cell function in ovarian cancer by regulating mitochondrial activity. Nature. 2018;562(7727):423\u20138.","journal-title":"Nature"},{"issue":"6","key":"2854_CR49","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/s41389-020-00246-2","volume":"9","author":"R Coelho","year":"2020","unstructured":"Coelho R, Ricardo S, Amaral AL, et al. Regulation of invasion and peritoneal dissemination of ovarian cancer by mesothelin manipulation. Oncogenesis. 2020;9(6):61.","journal-title":"Oncogenesis"},{"issue":"22","key":"2854_CR50","doi-asserted-by":"publisher","first-page":"12443","DOI":"10.3390\/ijms222212443","volume":"22","author":"TS Hilliard","year":"2021","unstructured":"Hilliard TS, Kowalski B, Iwamoto K, et al. Host mesothelin expression increases ovarian cancer metastasis in the peritoneal microenvironment. Int J Mol Sci. 2021;22(22):12443.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"2854_CR51","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1172\/JCI33775","volume":"118","author":"HA Kenny","year":"2008","unstructured":"Kenny HA, Kaur S, Coussens LM, Lengyel E. The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin. J Clin Invest. 2008;118(4):1367\u201379.","journal-title":"J Clin Invest"},{"issue":"1","key":"2854_CR52","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13048-021-00852-7","volume":"14","author":"MC Vos","year":"2021","unstructured":"Vos MC, van der Wurff A, van Kuppevelt TH, Massuger L. The role of MMP-14 in ovarian cancer: a systematic review. J Ovarian Res. 2021;14(1):101.","journal-title":"J Ovarian Res"},{"issue":"20","key":"2854_CR53","first-page":"5930","volume":"62","author":"CJ Scotton","year":"2002","unstructured":"Scotton CJ, Wilson JL, Scott K, et al. Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer. Cancer Res. 2002;62(20):5930\u20138.","journal-title":"Cancer Res"},{"issue":"6","key":"2854_CR54","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s10585-014-9658-1","volume":"31","author":"L Carduner","year":"2014","unstructured":"Carduner L, Leroy-Dudal J, Picot CR, Gallet O, Carreiras F, Kellouche S. Ascites-induced shift along epithelial\u2013mesenchymal spectrum in ovarian cancer cells: enhancement of their invasive behavior partly dependant on \u03b1v integrins. Clin Exp Metastasis. 2014;31(6):675\u201388.","journal-title":"Clin Exp Metastasis"},{"issue":"2","key":"2854_CR55","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/path.4889","volume":"242","author":"A Rynne-Vidal","year":"2017","unstructured":"Rynne-Vidal A, Au-Yeung CL, Jim\u00e9nez-Heffernan JA, et al. Mesothelial-to-mesenchymal transition as a possible therapeutic target in peritoneal metastasis of ovarian cancer. J Pathol. 2017;242(2):140\u201351.","journal-title":"J Pathol"},{"issue":"2\u20133","key":"2854_CR56","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s12026-009-8100-2","volume":"45","author":"EW Sorensen","year":"2009","unstructured":"Sorensen EW, Gerber SA, Sedlacek AL, Rybalko VY, Chan WM, Lord EM. Omental immune aggregates and tumor metastasis within the peritoneal cavity. Immunol Res. 2009;45(2\u20133):185\u201394.","journal-title":"Immunol Res"},{"issue":"3","key":"2854_CR57","first-page":"687","volume":"53","author":"A Hagiwara","year":"1993","unstructured":"Hagiwara A, Takahashi T, Sawai K, et al. Milky spots as the implantation site for malignant cells in peritoneal dissemination in mice. Cancer Res. 1993;53(3):687\u201392.","journal-title":"Cancer Res"},{"key":"2854_CR58","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.trsl.2016.03.016","volume":"175","author":"LG Coffman","year":"2016","unstructured":"Coffman LG, Burgos-Ojeda D, Wu R, Cho K, Bai S, Buckanovich RJ. New models of hematogenous ovarian cancer metastasis demonstrate preferential spread to the ovary and a requirement for the ovary for abdominal dissemination. Transl Res. 2016;175:92-102.e2.","journal-title":"Transl Res"},{"issue":"1","key":"2854_CR59","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ccr.2014.05.002","volume":"26","author":"S Pradeep","year":"2014","unstructured":"Pradeep S, Kim SW, Wu SY, et al. Hematogenous metastasis of ovarian cancer: rethinking mode of spread. Cancer Cell. 2014;26(1):77\u201391.","journal-title":"Cancer Cell"},{"issue":"4","key":"2854_CR60","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1097\/COC.0b013e318248da32","volume":"36","author":"K Matsuo","year":"2013","unstructured":"Matsuo K, Carter CM, Ahn EH, et al. Inferior vena cava filter placement and risk of hematogenous distant metastasis in ovarian cancer. Am J Clin Oncol. 2013;36(4):362\u20137.","journal-title":"Am J Clin Oncol"},{"issue":"1","key":"2854_CR61","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s13277-015-4299-9","volume":"37","author":"ML Gasparri","year":"2016","unstructured":"Gasparri ML, Savone D, Besharat RA, et al. Circulating tumor cells as trigger to hematogenous spreads and potential biomarkers to predict the prognosis in ovarian cancer. Tumour Biol. 2016;37(1):71\u20135.","journal-title":"Tumour Biol"},{"issue":"1","key":"2854_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2021.188660","volume":"1877","author":"J Yang","year":"2022","unstructured":"Yang J, Cheng S, Zhang N, Jin Y, Wang Y. Liquid biopsy for ovarian cancer using circulating tumor cells: recent advances on the path to precision medicine. Biochim Biophys Acta Rev Cancer. 2022;1877(1): 188660.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"1","key":"2854_CR63","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12943-022-01588-8","volume":"21","author":"JW Zhu","year":"2022","unstructured":"Zhu JW, Charkhchi P, Akbari MR. Potential clinical utility of liquid biopsies in ovarian cancer. Mol Cancer. 2022;21(1):114.","journal-title":"Mol Cancer"},{"issue":"1","key":"2854_CR64","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1186\/s12885-019-6470-y","volume":"19","author":"H Yue","year":"2019","unstructured":"Yue H, Wang J, Chen R, Hou X, Li J, Lu X. Gene signature characteristic of elevated stromal infiltration and activation is associated with increased risk of hematogenous and lymphatic metastasis in serous ovarian cancer. BMC Cancer. 2019;19(1):1266.","journal-title":"BMC Cancer"},{"issue":"2","key":"2854_CR65","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1158\/1535-7163.MCT-17-0643","volume":"17","author":"A Figueras","year":"2018","unstructured":"Figueras A, Alsina-Sanch\u00eds E, Lahiguera \u00c1, et al. A role for CXCR4 in peritoneal and hematogenous ovarian cancer dissemination. Mol Cancer Ther. 2018;17(2):532\u201343.","journal-title":"Mol Cancer Ther"},{"issue":"8","key":"2854_CR66","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1038\/s41591-020-0926-0","volume":"26","author":"B Izar","year":"2020","unstructured":"Izar B, Tirosh I, Stover EH, et al. A single-cell landscape of high-grade serous ovarian cancer. Nat Med. 2020;26(8):1271\u20139.","journal-title":"Nat Med"},{"issue":"8","key":"2854_CR67","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.500","volume":"11","author":"Q Hao","year":"2021","unstructured":"Hao Q, Li J, Zhang Q, et al. Single-cell transcriptomes reveal heterogeneity of high-grade serous ovarian carcinoma. Clin Transl Med. 2021;11(8): e500.","journal-title":"Clin Transl Med"},{"issue":"7","key":"2854_CR68","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1016\/j.cell.2018.03.073","volume":"173","author":"AW Zhang","year":"2018","unstructured":"Zhang AW, McPherson A, Milne K, et al. Interfaces of malignant and immunologic clonal dynamics in ovarian cancer. Cell. 2018;173(7):1755-1769.e22.","journal-title":"Cell"},{"issue":"1","key":"2854_CR69","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1084\/jem.20181170","volume":"216","author":"W Lee","year":"2019","unstructured":"Lee W, Ko SY, Mohamed MS, Kenny HA, Lengyel E, Naora H. Neutrophils facilitate ovarian cancer premetastatic niche formation in the omentum. J Exp Med. 2019;216(1):176\u201394.","journal-title":"J Exp Med"},{"issue":"1","key":"2854_CR70","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1093\/carcin\/bgr230","volume":"33","author":"J Cai","year":"2012","unstructured":"Cai J, Tang H, Xu L, et al. Fibroblasts in omentum activated by tumor cells promote ovarian cancer growth, adhesion and invasiveness. Carcinogenesis. 2012;33(1):20\u20139.","journal-title":"Carcinogenesis"},{"issue":"10","key":"2854_CR71","doi-asserted-by":"publisher","first-page":"4614","DOI":"10.1172\/JCI74778","volume":"124","author":"HA Kenny","year":"2014","unstructured":"Kenny HA, Chiang CY, White EA, et al. Mesothelial cells promote early ovarian cancer metastasis through fibronectin secretion. J Clin Invest. 2014;124(10):4614\u201328.","journal-title":"J Clin Invest"},{"issue":"3","key":"2854_CR72","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1158\/2159-8290.CD-17-0284","volume":"8","author":"O Pearce","year":"2018","unstructured":"Pearce O, Delaine-Smith RM, Maniati E, et al. Deconstruction of a metastatic tumor microenvironment reveals a common matrix response in human cancers. Cancer Discov. 2018;8(3):304\u201319.","journal-title":"Cancer Discov"},{"issue":"9","key":"2854_CR73","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1158\/0008-5472.CAN-18-2616","volume":"79","author":"S Natarajan","year":"2019","unstructured":"Natarajan S, Foreman KM, Soriano MI, et al. Collagen remodeling in the hypoxic tumor-mesothelial niche promotes ovarian cancer metastasis. Cancer Res. 2019;79(9):2271\u201384.","journal-title":"Cancer Res"},{"issue":"3","key":"2854_CR74","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","volume":"20","author":"E Sahai","year":"2020","unstructured":"Sahai E, Astsaturov I, Cukierman E, et al. A framework for advancing our understanding of cancer-associated fibroblasts. Nat Rev Cancer. 2020;20(3):174\u201386.","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"2854_CR75","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.trecan.2020.03.001","volume":"6","author":"C Attan\u00e9","year":"2020","unstructured":"Attan\u00e9 C, Muller C. Drilling for oil: tumor-surrounding adipocytes fueling cancer. Trends Cancer. 2020;6(7):593\u2013604.","journal-title":"Trends Cancer"},{"issue":"2","key":"2854_CR76","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/cac2.12130","volume":"41","author":"S Li","year":"2021","unstructured":"Li S, Zhang J, Qian S, et al. S100A8 promotes epithelial\u2013mesenchymal transition and metastasis under TGF-\u03b2\/USF2 axis in colorectal cancer. Cancer Commun. 2021;41(2):154\u201370.","journal-title":"Cancer Commun"},{"issue":"22","key":"2854_CR77","doi-asserted-by":"publisher","first-page":"4179","DOI":"10.1158\/0008-5472.CAN-22-1369","volume":"82","author":"T Fujishita","year":"2022","unstructured":"Fujishita T, Kojima Y, Kajino-Sakamoto R, et al. The cAMP\/PKA\/CREB and TGF\u03b2\/SMAD4 pathways regulate stemness and metastatic potential in colorectal cancer cells. Cancer Res. 2022;82(22):4179\u201390.","journal-title":"Cancer Res"},{"issue":"15","key":"2854_CR78","doi-asserted-by":"publisher","first-page":"4077","DOI":"10.1158\/1078-0432.CCR-17-0246","volume":"23","author":"C Wang","year":"2017","unstructured":"Wang C, Armasu SM, Kalli KR, et al. Pooled clustering of high-grade serous ovarian cancer gene expression leads to novel consensus subtypes associated with survival and surgical outcomes. Clin Cancer Res. 2017;23(15):4077\u201385.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2854_CR79","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13046-021-01899-6","volume":"40","author":"C Wang","year":"2021","unstructured":"Wang C, Wang J, Shen X, et al. LncRNA SPOCD1-AS from ovarian cancer extracellular vesicles remodels mesothelial cells to promote peritoneal metastasis via interacting with G3BP1. J Exp Clin Cancer Res. 2021;40(1):101.","journal-title":"J Exp Clin Cancer Res"},{"issue":"21","key":"2854_CR80","doi-asserted-by":"publisher","first-page":"11496","DOI":"10.3390\/ijms222111496","volume":"22","author":"L Pascual-Ant\u00f3n","year":"2021","unstructured":"Pascual-Ant\u00f3n L, Carde\u00f1es B, Sainz de la Cuesta R, et al. Mesothelial-to-mesenchymal transition and exosomes in peritoneal metastasis of ovarian cancer. Int J Mol Sci. 2021;22(21):11496.","journal-title":"Int J Mol Sci"},{"key":"2854_CR81","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.semcancer.2020.11.021","volume":"81","author":"K Ksi\u0105\u017cek","year":"2022","unstructured":"Ksi\u0105\u017cek K. Where does cellular senescence belong in the pathophysiology of ovarian cancer. Semin Cancer Biol. 2022;81:14\u201323.","journal-title":"Semin Cancer Biol"},{"issue":"7","key":"2854_CR82","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.bbadis.2012.10.013","volume":"1832","author":"T Marsh","year":"2013","unstructured":"Marsh T, Pietras K, McAllister SS. Fibroblasts as architects of cancer pathogenesis. Biochim Biophys Acta. 2013;1832(7):1070\u20138.","journal-title":"Biochim Biophys Acta"},{"key":"2854_CR83","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.764375","volume":"9","author":"D Del Rio","year":"2021","unstructured":"Del Rio D, Masi I, Caprara V, et al. Ovarian cancer-driven mesothelial-to-mesenchymal transition is triggered by the endothelin-1\/\u03b2-arr1 axis. Front Cell Dev Biol. 2021;9: 764375.","journal-title":"Front Cell Dev Biol"},{"key":"2854_CR84","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.matbio.2022.03.003","volume":"109","author":"K Kitami","year":"2022","unstructured":"Kitami K, Yoshihara M, Tamauchi S, et al. Peritoneal restoration by repurposing vitamin D inhibits ovarian cancer dissemination via blockade of the TGF-\u03b21\/thrombospondin-1 axis. Matrix Biol. 2022;109:70\u201390.","journal-title":"Matrix Biol"},{"key":"2854_CR85","doi-asserted-by":"publisher","first-page":"10204","DOI":"10.1038\/ncomms10204","volume":"6","author":"J Albrengues","year":"2015","unstructured":"Albrengues J, Bertero T, Grasset E, et al. Epigenetic switch drives the conversion of fibroblasts into proinvasive cancer-associated fibroblasts. Nat Commun. 2015;6:10204.","journal-title":"Nat Commun"},{"issue":"46","key":"2854_CR86","doi-asserted-by":"publisher","first-page":"20009","DOI":"10.1073\/pnas.1013805107","volume":"107","author":"Y Kojima","year":"2010","unstructured":"Kojima Y, Acar A, Eaton EN, et al. Autocrine TGF-beta and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts. Proc Natl Acad Sci USA. 2010;107(46):20009\u201314.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2854_CR87","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.684505","volume":"9","author":"Z Ji","year":"2021","unstructured":"Ji Z, Tian W, Gao W, Zang R, Wang H, Yang G. Cancer-associated fibroblast-derived interleukin-8 promotes ovarian cancer cell stemness and malignancy through the notch3-mediated signaling. Front Cell Dev Biol. 2021;9: 684505.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"2854_CR88","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12943-019-1049-4","volume":"18","author":"W Feng","year":"2019","unstructured":"Feng W, Dean DC, Hornicek FJ, Shi H, Duan Z. Exosomes promote pre-metastatic niche formation in ovarian cancer. Mol Cancer. 2019;18(1):124.","journal-title":"Mol Cancer"},{"issue":"10","key":"2854_CR89","doi-asserted-by":"publisher","first-page":"3603","DOI":"10.1172\/JCI62229","volume":"122","author":"SY Ko","year":"2012","unstructured":"Ko SY, Barengo N, Ladanyi A, et al. HOXA9 promotes ovarian cancer growth by stimulating cancer-associated fibroblasts. J Clin Invest. 2012;122(10):3603\u201317.","journal-title":"J Clin Invest"},{"issue":"16","key":"2854_CR90","doi-asserted-by":"publisher","first-page":"5016","DOI":"10.1158\/0008-5472.CAN-13-0023","volume":"73","author":"TL Yeung","year":"2013","unstructured":"Yeung TL, Leung CS, Wong KK, et al. TGF-\u03b2 modulates ovarian cancer invasion by upregulating CAF-derived versican in the tumor microenvironment. Cancer Res. 2013;73(16):5016\u201328.","journal-title":"Cancer Res"},{"issue":"1","key":"2854_CR91","doi-asserted-by":"publisher","first-page":"20190003","DOI":"10.1515\/pp-2019-0003","volume":"4","author":"RB Wilson","year":"2019","unstructured":"Wilson RB, Solass W, Archid R, Weinreich FJ, K\u00f6nigsrainer A, Reymond MA. Resistance to anoikis in transcoelomic shedding: the role of glycolytic enzymes. Pleura Peritoneum. 2019;4(1):20190003.","journal-title":"Pleura Peritoneum"},{"key":"2854_CR92","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.canlet.2020.08.030","volume":"492","author":"J Li","year":"2020","unstructured":"Li J, Liu X, Zang S, et al. Small extracellular vesicle-bound vascular endothelial growth factor secreted by carcinoma-associated fibroblasts promotes angiogenesis in a bevacizumab-resistant manner. Cancer Lett. 2020;492:71\u201383.","journal-title":"Cancer Lett"},{"key":"2854_CR93","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.biocel.2016.12.002","volume":"84","author":"F Xiang","year":"2017","unstructured":"Xiang F, Wu K, Liu Y, et al. Omental adipocytes enhance the invasiveness of gastric cancer cells by oleic acid-induced activation of the PI3K-Akt signaling pathway. Int J Biochem Cell Biol. 2017;84:14\u201321.","journal-title":"Int J Biochem Cell Biol"},{"issue":"17","key":"2854_CR94","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1038\/s41388-017-0093-z","volume":"37","author":"A Ladanyi","year":"2018","unstructured":"Ladanyi A, Mukherjee A, Kenny HA, et al. Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis. Oncogene. 2018;37(17):2285\u2013301.","journal-title":"Oncogene"},{"issue":"22","key":"2854_CR95","doi-asserted-by":"publisher","first-page":"4366","DOI":"10.1038\/s41388-019-0728-3","volume":"38","author":"B John","year":"2019","unstructured":"John B, Naczki C, Patel C, et al. Regulation of the bi-directional cross-talk between ovarian cancer cells and adipocytes by SPARC. Oncogene. 2019;38(22):4366\u201383.","journal-title":"Oncogene"},{"issue":"12","key":"2854_CR96","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0081859","volume":"8","author":"A Nowicka","year":"2013","unstructured":"Nowicka A, Marini FC, Solley TN, et al. Human omental-derived adipose stem cells increase ovarian cancer proliferation, migration, and chemoresistance. PLoS ONE. 2013;8(12): e81859.","journal-title":"PLoS ONE"},{"issue":"1","key":"2854_CR97","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/ijgo.12986","volume":"148","author":"L Salman","year":"2020","unstructured":"Salman L, Sabah G, Jakobson-Setton A, Raban O, Yeoshoua E, Eitan R. Neutrophil-to-lymphocyte ratio as a prognostic factor in advanced stage ovarian carcinoma treated with neoadjuvant chemotherapy. Int J Gynaecol Obstet. 2020;148(1):102\u20136.","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"2854_CR98","doi-asserted-by":"publisher","first-page":"55","DOI":"10.5468\/ogs.2020.63.1.55","volume":"63","author":"D Jeerakornpassawat","year":"2020","unstructured":"Jeerakornpassawat D, Suprasert P. Potential predictors for chemotherapeutic response and prognosis in epithelial ovarian, fallopian tube and primary peritoneal cancer patients treated with platinum-based chemotherapy. Obstet Gynecol Sci. 2020;63(1):55\u201363.","journal-title":"Obstet Gynecol Sci"},{"issue":"3","key":"2854_CR99","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.ccell.2019.08.003","volume":"36","author":"R Jackstadt","year":"2019","unstructured":"Jackstadt R, van Hooff SR, Leach JD, et al. Epithelial NOTCH signaling rewires the tumor microenvironment of colorectal cancer to drive poor-prognosis subtypes and metastasis. Cancer Cell. 2019;36(3):319-336.e7.","journal-title":"Cancer Cell"},{"key":"2854_CR100","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.659996","volume":"12","author":"S SenGupta","year":"2021","unstructured":"SenGupta S, Hein LE, Xu Y, et al. Triple-negative breast cancer cells recruit neutrophils by secreting TGF-\u03b2 and CXCR2 ligands. Front Immunol. 2021;12: 659996.","journal-title":"Front Immunol"},{"issue":"11","key":"2854_CR101","doi-asserted-by":"publisher","first-page":"4157","DOI":"10.1172\/JCI87252","volume":"126","author":"M Yin","year":"2016","unstructured":"Yin M, Li X, Tan S, et al. Tumor-associated macrophages drive spheroid formation during early transcoelomic metastasis of ovarian cancer. J Clin Invest. 2016;126(11):4157\u201373.","journal-title":"J Clin Invest"},{"issue":"12","key":"2854_CR102","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-003973","volume":"9","author":"L Long","year":"2021","unstructured":"Long L, Hu Y, Long T, et al. Tumor-associated macrophages induced spheroid formation by CCL18-ZEB1-M-CSF feedback loop to promote transcoelomic metastasis of ovarian cancer. J Immunother Cancer. 2021;9(12): e003973.","journal-title":"J Immunother Cancer"},{"issue":"4","key":"2854_CR103","first-page":"1553","volume":"34","author":"E Smolle","year":"2014","unstructured":"Smolle E, Taucher V, Haybaeck J. Malignant ascites in ovarian cancer and the role of targeted therapeutics. Anticancer Res. 2014;34(4):1553\u201361.","journal-title":"Anticancer Res"},{"key":"2854_CR104","doi-asserted-by":"publisher","first-page":"8687","DOI":"10.2147\/OTT.S216355","volume":"12","author":"M Yin","year":"2019","unstructured":"Yin M, Shen J, Yu S, et al. Tumor-associated macrophages (TAMs): a critical activator in ovarian cancer metastasis. Onco Targets Ther. 2019;12:8687\u201399.","journal-title":"Onco Targets Ther"},{"issue":"13","key":"2854_CR105","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.3390\/cancers13133253","volume":"13","author":"I Larionova","year":"2021","unstructured":"Larionova I, Kazakova E, Gerashchenko T, Kzhyshkowska J. New angiogenic regulators produced by TAMs: perspective for targeting tumor angiogenesis. Cancers. 2021;13(13):3253.","journal-title":"Cancers"},{"issue":"5","key":"2854_CR106","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2018.1424672","volume":"7","author":"S Lieber","year":"2018","unstructured":"Lieber S, Reinartz S, Raifer H, et al. Prognosis of ovarian cancer is associated with effector memory CD8(+) T cell accumulation in ascites, CXCL9 levels and activation-triggered signal transduction in T cells. Oncoimmunology. 2018;7(5): e1424672.","journal-title":"Oncoimmunology"},{"issue":"11","key":"2854_CR107","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2015.1030561","volume":"4","author":"M Jang","year":"2015","unstructured":"Jang M, Yew PY, Hasegawa K, et al. Characterization of T cell repertoire of blood, tumor, and ascites in ovarian cancer patients using next generation sequencing. Oncoimmunology. 2015;4(11): e1030561.","journal-title":"Oncoimmunology"},{"issue":"8","key":"2854_CR108","first-page":"2875","volume":"29","author":"RL Giuntoli 2nd","year":"2009","unstructured":"Giuntoli RL 2nd, Webb TJ, Zoso A, et al. Ovarian cancer-associated ascites demonstrates altered immune environment: implications for antitumor immunity. Anticancer Res. 2009;29(8):2875\u201384.","journal-title":"Anticancer Res"},{"issue":"4","key":"2854_CR109","doi-asserted-by":"publisher","first-page":"179","DOI":"10.5603\/GP.2019.0032","volume":"90","author":"MM Dutsch-Wicherek","year":"2019","unstructured":"Dutsch-Wicherek MM, Szubert S, Dziobek K, et al. Analysis of the treg cell population in the peripheral blood of ovarian cancer patients in relation to the long-term outcomes. Ginekol Pol. 2019;90(4):179\u201384.","journal-title":"Ginekol Pol"},{"issue":"24","key":"2854_CR110","doi-asserted-by":"publisher","first-page":"7106","DOI":"10.1158\/0008-5472.CAN-16-1456","volume":"76","author":"A Metelli","year":"2016","unstructured":"Metelli A, Wu BX, Fugle CW, et al. Surface expression of TGF\u03b2 docking receptor GARP promotes oncogenesis and immune tolerance in breast cancer. Cancer Res. 2016;76(24):7106\u201317.","journal-title":"Cancer Res"},{"issue":"11","key":"2854_CR111","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1038\/bjc.2012.468","volume":"107","author":"NG Gavalas","year":"2012","unstructured":"Gavalas NG, Tsiatas M, Tsitsilonis O, et al. VEGF directly suppresses activation of T cells from ascites secondary to ovarian cancer via VEGF receptor type 2. Br J Cancer. 2012;107(11):1869\u201375.","journal-title":"Br J Cancer"},{"issue":"6","key":"2854_CR112","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1158\/2326-6066.CIR-19-0360","volume":"8","author":"PE de Almeida","year":"2020","unstructured":"de Almeida PE, Mak J, Hernandez G, et al. Anti-VEGF treatment enhances CD8(+) T-cell antitumor activity by amplifying hypoxia. Cancer Immunol Res. 2020;8(6):806\u201318.","journal-title":"Cancer Immunol Res"},{"issue":"1","key":"2854_CR113","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s10585-015-9753-y","volume":"33","author":"J Miku\u0142a-Pietrasik","year":"2016","unstructured":"Miku\u0142a-Pietrasik J, Sosi\u0144ska P, Naumowicz E, et al. Senescent peritoneal mesothelium induces a pro-angiogenic phenotype in ovarian cancer cells in vitro and in a mouse xenograft model in vivo. Clin Exp Metastasis. 2016;33(1):15\u201327.","journal-title":"Clin Exp Metastasis"},{"issue":"1","key":"2854_CR114","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0022-4804(03)00307-X","volume":"115","author":"A Sako","year":"2003","unstructured":"Sako A, Kitayama J, Yamaguchi H, et al. Vascular endothelial growth factor synthesis by human omental mesothelial cells is augmented by fibroblast growth factor-2: possible role of mesothelial cell on the development of peritoneal metastasis. J Surg Res. 2003;115(1):113\u201320.","journal-title":"J Surg Res"},{"issue":"2","key":"2854_CR115","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1093\/carcin\/bgz083","volume":"41","author":"H Tang","year":"2020","unstructured":"Tang H, Chu Y, Huang Z, Cai J, Wang Z. The metastatic phenotype shift toward myofibroblast of adipose-derived mesenchymal stem cells promotes ovarian cancer progression. Carcinogenesis. 2020;41(2):182\u201393.","journal-title":"Carcinogenesis"},{"issue":"1","key":"2854_CR116","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.canlet.2012.07.020","volume":"326","author":"M Castells","year":"2012","unstructured":"Castells M, Thibault B, Mery E, et al. Ovarian ascites-derived hospicells promote angiogenesis via activation of macrophages. Cancer Lett. 2012;326(1):59\u201368.","journal-title":"Cancer Lett"},{"issue":"9","key":"2854_CR117","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1002\/ijc.24881","volume":"126","author":"L Martinet","year":"2010","unstructured":"Martinet L, Poupot R, Mirshahi P, et al. Hospicells derived from ovarian cancer stroma inhibit T-cell immune responses. Int J Cancer. 2010;126(9):2143\u201352.","journal-title":"Int J Cancer"},{"issue":"2","key":"2854_CR118","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s00404-018-4952-9","volume":"299","author":"J Krugmann","year":"2019","unstructured":"Krugmann J, Schwarz CL, Melcher B, et al. Malignant ascites occurs most often in patients with high-grade serous papillary ovarian cancer at initial diagnosis: a retrospective analysis of 191 women treated at Bayreuth Hospital, 2006\u20132015. Arch Gynecol Obstet. 2019;299(2):515\u201323.","journal-title":"Arch Gynecol Obstet"},{"issue":"12","key":"2854_CR119","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1136\/ijgc-2021-002978","volume":"31","author":"D Nasioudis","year":"2021","unstructured":"Nasioudis D, Byrne M, Ko EM, et al. Ascites volume at the time of primary debulking and overall survival of patients with advanced epithelial ovarian cancer. Int J Gynecol Cancer. 2021;31(12):1579\u201383.","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"2854_CR120","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1111\/jog.14682","volume":"47","author":"Q Quan","year":"2021","unstructured":"Quan Q, Zhou S, Liu Y, et al. Relationship between ascites volume and clinical outcomes in epithelial ovarian cancer. J Obstet Gynaecol Res. 2021;47(4):1527\u201335.","journal-title":"J Obstet Gynaecol Res"},{"issue":"16","key":"2854_CR121","doi-asserted-by":"publisher","first-page":"7983","DOI":"10.1158\/0008-5472.CAN-05-4381","volume":"66","author":"KS Kim","year":"2006","unstructured":"Kim KS, Sengupta S, Berk M, et al. Hypoxia enhances lysophosphatidic acid responsiveness in ovarian cancer cells and lysophosphatidic acid induces ovarian tumor metastasis in vivo. Cancer Res. 2006;66(16):7983\u201390.","journal-title":"Cancer Res"},{"issue":"1035","key":"2854_CR122","doi-asserted-by":"publisher","first-page":"20130676","DOI":"10.1259\/bjr.20130676","volume":"87","author":"SR McKeown","year":"2014","unstructured":"McKeown SR. Defining normoxia, physoxia and hypoxia in tumours-implications for treatment response. Br J Radiol. 2014;87(1035):20130676.","journal-title":"Br J Radiol"},{"issue":"1","key":"2854_CR123","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/0009-8981(95)06093-S","volume":"239","author":"AV Greco","year":"1995","unstructured":"Greco AV, Mingrone G, Gasbarrini G. Free fatty acid analysis in ascitic fluid improves diagnosis in malignant abdominal tumors. Clin Chim Acta. 1995;239(1):13\u201322.","journal-title":"Clin Chim Acta"},{"issue":"37","key":"2854_CR124","doi-asserted-by":"publisher","first-page":"5127","DOI":"10.1038\/s41388-018-0317-x","volume":"37","author":"S Al Habyan","year":"2018","unstructured":"Al Habyan S, Kalos C, Szymborski J, McCaffrey L. Multicellular detachment generates metastatic spheroids during intra-abdominal dissemination in epithelial ovarian cancer. Oncogene. 2018;37(37):5127\u201335.","journal-title":"Oncogene"},{"key":"2854_CR125","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3389\/fonc.2015.00245","volume":"5","author":"A Cho","year":"2015","unstructured":"Cho A, Howell VM, Colvin EK. The extracellular matrix in epithelial ovarian cancer\u2014a piece of a puzzle. Front Oncol. 2015;5:245.","journal-title":"Front Oncol"},{"issue":"2","key":"2854_CR126","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/0022-4804(87)90109-0","volume":"42","author":"RN Garrison","year":"1987","unstructured":"Garrison RN, Galloway RH, Heuser LS. Mechanisms of malignant ascites production. J Surg Res. 1987;42(2):126\u201332.","journal-title":"J Surg Res"},{"issue":"11","key":"2854_CR127","first-page":"2631","volume":"53","author":"JA Nagy","year":"1993","unstructured":"Nagy JA, Herzberg KT, Dvorak JM, Dvorak HF. Pathogenesis of malignant ascites formation: initiating events that lead to fluid accumulation. Cancer Res. 1993;53(11):2631\u201343.","journal-title":"Cancer Res"},{"issue":"3","key":"2854_CR128","doi-asserted-by":"publisher","DOI":"10.1172\/JCI140315","volume":"131","author":"S Zhang","year":"2021","unstructured":"Zhang S, Xie B, Wang L, et al. Macrophage-mediated vascular permeability via VLA4\/VCAM1 pathway dictates ascites development in ovarian cancer. J Clin Invest. 2021;131(3): e140315.","journal-title":"J Clin Invest"},{"issue":"7","key":"2854_CR129","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1002\/ijc.32990","volume":"147","author":"Y Gong","year":"2020","unstructured":"Gong Y, Yang J, Wang Y, Xue L, Wang J. Metabolic factors contribute to T-cell inhibition in the ovarian cancer ascites. Int J Cancer. 2020;147(7):1768\u201377.","journal-title":"Int J Cancer"},{"issue":"2","key":"2854_CR130","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2018.1535730","volume":"8","author":"E R\u00e5destad","year":"2019","unstructured":"R\u00e5destad E, Klynning C, Stikvoort A, et al. Immune profiling and identification of prognostic immune-related risk factors in human ovarian cancer. Oncoimmunology. 2019;8(2): e1535730.","journal-title":"Oncoimmunology"},{"issue":"3","key":"2854_CR131","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s00262-014-1636-6","volume":"64","author":"J Landskron","year":"2015","unstructured":"Landskron J, Helland \u00d8, Torgersen KM, et al. Activated regulatory and memory T-cells accumulate in malignant ascites from ovarian carcinoma patients. Cancer Immunol Immunother. 2015;64(3):337\u201347.","journal-title":"Cancer Immunol Immunother"},{"issue":"577","key":"2854_CR132","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abb0192","volume":"13","author":"E Foord","year":"2021","unstructured":"Foord E, Arruda L, Gaballa A, Klynning C, Uhlin M. Characterization of ascites- and tumor-infiltrating \u03b3\u03b4 T cells reveals distinct repertoires and a beneficial role in ovarian cancer. Sci Transl Med. 2021;13(577): eabb0192.","journal-title":"Sci Transl Med"},{"issue":"15","key":"2854_CR133","doi-asserted-by":"publisher","first-page":"3744","DOI":"10.1158\/0008-5472.CAN-11-2695","volume":"72","author":"TJ Webb","year":"2012","unstructured":"Webb TJ, Li X, Giuntoli RL 2nd, et al. Molecular identification of GD3 as a suppressor of the innate immune response in ovarian cancer. Cancer Res. 2012;72(15):3744\u201352.","journal-title":"Cancer Res"},{"issue":"12","key":"2854_CR134","doi-asserted-by":"publisher","first-page":"6560","DOI":"10.3390\/ijms22126560","volume":"22","author":"H Wang","year":"2021","unstructured":"Wang H, Yung M, Ngan H, Chan K, Chan DW. The impact of the tumor microenvironment on macrophage polarization in cancer metastatic progression. Int J Mol Sci. 2021;22(12):6560.","journal-title":"Int J Mol Sci"},{"key":"2854_CR135","doi-asserted-by":"publisher","first-page":"691","DOI":"10.3389\/fimmu.2019.00691","volume":"10","author":"K Ok\u0142a","year":"2019","unstructured":"Ok\u0142a K, Czerwonka A, Wawruszak A, et al. Clinical relevance and immunosuppressive pattern of circulating and infiltrating subsets of myeloid-derived suppressor cells (MDSCs) in epithelial ovarian cancer. Front Immunol. 2019;10:691.","journal-title":"Front Immunol"},{"issue":"4","key":"2854_CR136","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2014.1001224","volume":"4","author":"S Pesce","year":"2015","unstructured":"Pesce S, Tabellini G, Cantoni C, et al. B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape. Oncoimmunology. 2015;4(4): e1001224.","journal-title":"Oncoimmunology"},{"key":"2854_CR137","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/j.1749-6632.2000.tb06550.x","volume":"905","author":"X Fang","year":"2000","unstructured":"Fang X, Gaudette D, Furui T, et al. Lysophospholipid growth factors in the initiation, progression, metastases, and management of ovarian cancer. Ann N Y Acad Sci. 2000;905:188\u2013208.","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"2854_CR138","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/s41419-021-03490-5","volume":"12","author":"J Cai","year":"2021","unstructured":"Cai J, Gong L, Li G, Guo J, Yi X, Wang Z. Exosomes in ovarian cancer ascites promote epithelial\u2013mesenchymal transition of ovarian cancer cells by delivery of miR-6780b-5p. Cell Death Dis. 2021;12(2):210.","journal-title":"Cell Death Dis"},{"issue":"9","key":"2854_CR139","doi-asserted-by":"publisher","first-page":"3125","DOI":"10.3390\/ijms21093125","volume":"21","author":"D Baci","year":"2020","unstructured":"Baci D, Bosi A, Gallazzi M, et al. The ovarian cancer tumor immune microenvironment (TIME) as target for therapy: a focus on innate immunity cells as therapeutic effectors. Int J Mol Sci. 2020;21(9):3125.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"2854_CR140","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1158\/1078-0432.CCR-10-2429","volume":"17","author":"S Liao","year":"2011","unstructured":"Liao S, Liu J, Lin P, Shi T, Jain RK, Xu L. TGF-beta blockade controls ascites by preventing abnormalization of lymphatic vessels in orthotopic human ovarian carcinoma models. Clin Cancer Res. 2011;17(6):1415\u201324.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"2854_CR141","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s10585-021-10077-z","volume":"38","author":"A Kumari","year":"2021","unstructured":"Kumari A, Shonibare Z, Monavarian M, et al. TGF\u03b2 signaling networks in ovarian cancer progression and plasticity. Clin Exp Metastasis. 2021;38(2):139\u201361.","journal-title":"Clin Exp Metastasis"},{"key":"2854_CR142","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cca.2018.03.019","volume":"482","author":"V Dalal","year":"2018","unstructured":"Dalal V, Kumar R, Kumar S, et al. Biomarker potential of IL-6 and VEGF-A in ascitic fluid of epithelial ovarian cancer patients. Clin Chim Acta. 2018;482:27\u201332.","journal-title":"Clin Chim Acta"}],"container-title":["Cancer Cell International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-023-02854-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12935-023-02854-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12935-023-02854-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T15:19:11Z","timestamp":1701789551000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerci.biomedcentral.com\/articles\/10.1186\/s12935-023-02854-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,25]]},"references-count":142,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2854"],"URL":"https:\/\/doi.org\/10.1186\/s12935-023-02854-5","relation":{},"ISSN":["1475-2867"],"issn-type":[{"value":"1475-2867","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,25]]},"assertion":[{"value":"2 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the authors have approved the final manuscript for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11"}}